This article is published in association with European Investment Bank. The European Investment Bank (EIB) is providing €20 million in venture-debt financing to German medical-technology company Protembis to develop a next-generation device for protecting the brains of patients who undergo certain heart treatments. The funding is to support clinical trials, research, development and market access for […]